Document is current
Any future updates will be listed below
-
Authors
Chana, Chetan K. https://orcid.org/0000-0002-1176-0190
Ben Makhlouf, Ines https://orcid.org/0009-0008-1960-3748
Kim, Jaeyoun https://orcid.org/0000-0001-8809-8054
Yu, April J. Y. https://orcid.org/0009-0005-4973-208X
Moatti, Nathalie
Orlicky, Stephen
Wong, Cassandra J. https://orcid.org/0009-0009-7292-3780
Baronijan, Leon https://orcid.org/0009-0002-8259-7885
Tang, XiaoJing
Mao, Daniel
Larsen, Brett
McGary, Laura
Seale, Brendon
Mader, Pavel
Ceccarelli, Derek F.
Barbulescu, Philip
Martin, Alberto https://orcid.org/0000-0002-1260-7710
Durocher, Daniel
Pelletier, Laurence https://orcid.org/0000-0003-1171-4618
Gingras, Anne-Claude https://orcid.org/0000-0002-6090-4437
Sicheri, Frank https://orcid.org/0000-0002-9824-2117
-
Funding
Funding for this research was provided by:
Terry Fox Research Institute (TFRI-1107-04)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-180338)
Gouvernement du Canada | Canadian Institutes of Health Research (FRN-167279)
Gouvernement du Canada | Canadian Institutes of Health Research (TFRI-1107-04)
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 4 March 2026
First Online: 9 April 2026
Competing interests
: F.S. and D.D. are founders and consultants for Repare Therapeutics and Induxion Therapeutics. The other authors declare no competing interests.
